| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 175.35M | 176.97M | 224.41M | 200.99M | 148.58M | 114.70M |
| Gross Profit | 28.29M | 27.49M | 43.29M | 38.91M | 30.48M | 19.83M |
| EBITDA | 15.62M | 14.63M | 28.61M | 25.36M | 20.62M | 13.08M |
| Net Income | 4.83M | 4.17M | 16.72M | 13.79M | 8.55M | 4.15M |
Balance Sheet | ||||||
| Total Assets | 165.81M | 168.27M | 174.06M | 174.43M | 165.19M | 157.59M |
| Cash, Cash Equivalents and Short-Term Investments | 15.53M | 15.56M | 32.53M | 35.57M | 35.74M | 36.09M |
| Total Debt | 2.14M | 2.13M | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 40.76M | 40.83M | 40.06M | 42.77M | 33.70M | 28.13M |
| Stockholders Equity | 125.05M | 127.44M | 133.99M | 131.66M | 131.50M | 129.46M |
Cash Flow | ||||||
| Free Cash Flow | 4.57M | -7.62M | 10.96M | 13.66M | 6.02M | 7.20M |
| Operating Cash Flow | 26.72M | 12.14M | 20.55M | 19.86M | 10.40M | 12.45M |
| Investing Cash Flow | -19.59M | -18.06M | -8.98M | -6.20M | -3.97M | -3.22M |
| Financing Cash Flow | -7.96M | -11.04M | -14.61M | -13.83M | -6.78M | -6.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £916.17M | 15.43 | 33.12% | 1.01% | 24.42% | 103.25% | |
70 Outperform | £179.65M | 10.69 | 6.13% | 1.02% | 14.49% | 76.33% | |
65 Neutral | £102.61M | 7.63 | 3.83% | 6.69% | -13.30% | -60.03% | |
64 Neutral | £7.43B | 29.74 | 13.42% | 1.26% | -1.97% | 40.55% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | £1.08B | 22.48 | 8.58% | 3.30% | -6.95% | -52.08% | |
62 Neutral | £564.85M | 28.89 | 8.04% | 4.87% | -7.30% | -59.71% |